On-Demand Learning

Patent

Recorded on: Feb. 24, 2011

EUGENE QUINN: I guess I should just start. SPEAKER 2: Carry on, and don't forget our web audience, see if we have any questions. EUGENE QUINN: OK, and which way do I look for the web audience? Into that camera? Hello everybody out there on the web. My name's Gene Quinn. John introduced me earlier. I've taught the PLI Patent Bar review course with John now for 10 years, and usually he introduces me by Gene, wave. So it was nice to get a little ...

Recorded on: Mar. 5, 2012

DOUGLAS R. NEMEC: Morning, everybody. And thank you again for coming out for the Patent Law Institute. It's great to see so many full seats out there. And those of you in the webcast audience, we can't see you, so rest assured. But we know you're there, and we appreciate your joining as well. And thanks also to Bob for the great keynote address. It looks like we've got an exciting couple of years ahead, certainly in the prosecution world, but in ...

Recorded on: Mar. 19, 2013

[? DOUGLAS R. NEMEC: Brian ?] managed to cover about 800 pages of Federal Register reports on Patent Office rule-making. We'll now turn it over to Denise De Mory to cover 800 or more pages of court decisions from the last year from Supreme Court, Federal Circuit, and other courts. You've got a challenge on your hands there. Denise is a founding partner at Bunsow, De Mory, Smith, and Allison in Silicon Valley. She's got about 20 years of experience ...

Recorded on: Feb. 24, 2011

DOUGLAS R. NEMEC: Good morning, everybody. It's time now for what I consider to be one of the critical components of this program. Patent Law Institute was debuted in 2007 at a time when the Supreme Court was absolutely on fire with patent issues. We had the Merck versus Integra case coming out a couple years earlier. EBay, MedImmune versus Genentech, Microsoft. Really an unprecedented frequency of patent cases coming out of the Supreme Court at that ...

Recorded on: Sep. 28, 2012

MARK SAMUELS: What I'd like to do now is go ahead and introduce Craig Kaufman. Unless there are any questions, we're going to move right into the program, perhaps a few minutes early. Craig is a chemist, much like myself. Originally, he got his undergraduate degree at Occidental College in chemistry and a master's in chemistry from Duke. Craig then went to the George Washington University Law School, where he received his JD with high honors and ...

Recorded on: Feb. 9, 2012

EUGENE T. PEREZ: Good morning, everyone. Just apologies ahead of time. I'm just getting over a cold, so my voice is not 100%, but no big deal, I think. Some of you actually look familiar, I think from last year. Before, we used to have, maybe, 30 some slides. And I know this first hour, there's a lot more slides this year. Well, really it's because we have this new law. And there's a lot more post-grant procedures available. The idea of this first ...

Recorded on: Nov. 6, 2012

Taken from the briefing Role of Patents in Business and the Impact of the America Invents Actrecorded November, 2012. Changes instituted by the recently enacted America Invents Act will impact all industries. This presentation will summarize the critical role patents are playing in business decisions today. Lecture Topics  [Total Time: 01:05:25] An overview of the value of patents and how they are being leveraged as a business ...

Recorded on: Dec. 6, 2012

LAWRENCE ROSEN: Well, let me introduce two people that told me, after I invited them, that they really don't know that much about open source. But they do know a lot about open standards. And one of the things that I was particularly anxious to get a presentation on this year is about the relationship between the standards organizations that mostly worry about patents, although they ought to think about copyrights as well, and open source, and the ...

Recorded on: Jul. 24, 2012

JOHN WHITE: With that, let me introduce our first speaker. We're going to be talking about Section 102 as it exists now and the MPEP and the CAFC. And our first speaker will be Patrick Jewik. He's from Kilpatrick Townsend & Stockton. He's right here in San Francisco. And you can read Patrick's bio in your material. Before he became an examiner, he was in chip manufacturing at IBM, wore a bunny suit and that sort of thing. And he was an examiner ...

Recorded on: Jul. 23, 2013

JOHN: Welcome back. It's 11:15. We're back on cameras that work for all those out there in the ether. And welcome back to all those in live attendance as well. Our next segment of the program is fascinating-- not that the others were not fascinating as well. Because it's all very interesting. I feel like a frequent flyer customer. When I'm standing in line with my boarding pass and they say, our preferred customers, please, and I obviously don't go. ...

Recorded on: Feb. 24, 2011

JOHN M. WHITE: With that, let me introduce our next speaker, Philippe Signore. He is a partner at Oblon. And he's been telling us about patent reform for several years now. At least one, maybe two. And each time, he tells us his view of the handicap, whether it will occur or not. And so I'm interested to hear from him again on that front. He has a law degree from Georgetown and a physics degree from University of Florida. So he has a PhD in physics. ...

Recorded on: Apr. 2, 2013

DAVID K. BARR: Switch to our second topic which is biologic and biosimilar drug products. And I'm fortunate to have with me sharing this topic, Betty Ryberg. And introducing Betty Ryberg, she joined Novartis in 2008 as vice president of US IP litigation for group intellectual property. And she leads Novartis Corporation's IP group. Before joining Novartis, Betty was a colleague of ours at Kaye Scholer. And she worked on numerous pharmaceutical biotech ...

Recorded on: Mar. 5, 2012

SCOTT M. ALTER: OK, we're going to go ahead and get started. Good morning everyone. Welcome back. I'm going to talk about inter partes review and post grant review. We have new laws, new rules, and new strategies. It's a brave new world, so a lot to cover. We have two terrific speakers to talk about the subject this morning. To my immediate right is Bill Weimer, my colleague at Faegre Baker Daniels where he is a partner in the intellectual property ...

Recorded on: Mar. 5, 2012

SCOTT M. ALTER: Next panel is going to be relating to product clearances, design-arounds, avoiding injunctions, and related type of topics. And we are very fortunate enough to have two great speakers talking about these issues today. One of them is Greg Kirsch, two down from me there. Greg is a partner and registered patent attorney with Ballard Spahr in Atlanta. Greg leads the firm's software, electronics, and communications technology patent team, ...

Recorded on: Mar. 5, 2012

SCOTT ALTER: Just going to go right into our next session here, which is the continuing importance of opinions of counsel in light of recent court decisions. And for that, we have Jeff Zachmann to talk to us about that. And he is counsel on IBM's corporate litigation department. He's been with IBM since 1988. Since joining the litigation department in '92, has managed over 100 IP litigations for IBM, the majority being patent cases. So he has a lot ...

Recorded on: Mar. 5, 2012

SPEAKER: OK, thank you, gentlemen. I think if there any questions, you guys will be around for a little bit? Because we're right up against the next session here, which is What's Hot in Patent Licensing Law? And for that we have Peter Brown, coming up on this side here to talk to us about that. Peter is the national leader of Baker-Hostetler's technology law practice, and resides in the New York City office. He maintains an active practice in technology ...

Recorded on: Jul. 24, 2012

JOHN M WHITE: OK. It's 11:15. Welcome back. And to all those of you out there in web land, welcome back. This is our next segment of the program, Prior Art and Obviousness, and at this point we jump into the future. Our speaker will be Len Svensson. He comes to us from Birch, Stewart, Kolasch & Birch. He is with their office in San Diego, but once upon a time he was back East with the rest of the firm and came out to sunny California, what 15 years ...

Recorded on: Jul. 23, 2013

JOHN WHITE: Good afternoon. We are welcoming ourselves back, I'm welcoming you back to the last segment of our program today. We'll run until, I think, five-- BOB SPAR: Do you have questions on there? JOHN WHITE: --30? Yes. And we have some questions. We run until 5 o'clock, I'm sorry. I was too enthusiastic about this, 5:30. But we have some questions. Let me go over some questions we have from those on the web. And I'll try to extend this toward ...

Recorded on: Apr. 9, 2012

DANIEL L. REISNER: Our second session is going to cover major decisions in the past year, including pending Supreme Court and Federal Circuit en banc petitions. Our speaker is Mr. Ben Hsing, a partner of mine at Kaye Scholer. He's been practicing in the area of patent litigation for the past 20 years. His practice includes patent litigation before US District Courts, the US international Trade Commission, and the Federal Circuit. His clients include ...

Recorded on: Apr. 9, 2012

DANIEL L. REISNER: So I'd like to thank Ian and Dean for their excellent presentation on the AIA and their in-house counsel and patent prosecution perspective. We're going to start the next hour session on the AIA. First, I'm going to answer a couple of questions that we got from the web at the end of the last hour. Then we're going to try some new technology here, and going to poll all of you on your views on the AIA, and then we'll go into my presentation. DAVID ...

Recorded on: Apr. 9, 2012

DANIEL L. REISNER: Our next two speakers on the AIA are from Pfizer. Dean Olson has over 25 years experience as a patent lawyer. He joined Pfizer in 1989 and is currently assistant general counsel with responsibility for numerous therapeutic areas. Mr. Olson has also been a product patent attorney with Pfizer covering many products, including Caduet, Norvasc, and Viagra. Prior to joining Pfizer, Mr. Olson was employed at United Technologies Corporation ...

Recorded on: Jun. 7, 2012

GARY M. HNATH: So how many people have heard of litigating Section 337 cases of the ITC. Just a show of hands. That's more than half, that's almost everybody. That's very impressive. If I'd asked that question five years ago, I probably would have gotten maybe one or two people in the audience, so a lot more people know about Section 337. I don't know your depth of knowledge, but my goal is at the end of the hour to tell you enough about Section 337, ...

Recorded on: Jun. 13, 2011

SPEAKER 1: OK. So our next speaker is Gary Hnath. Now, Gary Hnath is the Mayer Brown filling in former Mayer Brown partner sandwich. So first, there's Brandon. And I'm actually also former Mayer Brown. And Gary and I had the great pleasure of traveling around China, what, almost 2 years ago, now. I actually still have on my notes the itinerary for this trip since there were days, and we were talking about ITC cases to folks in China, there were days ...

Recorded on: Jun. 6, 2013

GARY M. HNATH: Good afternoon, everybody. My name is Gary Hnath, and it's my great pleasure to talk to you about Section 337 cases at the ITC. How many of you have are familiar with the use of the ITC as a place to enforce patents? A few people. If I asked that question three or four years ago, people would put probably maybe one or two hands in the audience. But it is becoming increasingly important. Just yesterday, around 4 o'clock morning, we ...

Released on: May. 16, 2013

Please note that CLE credit is not available for this program.Lecture Topics  [Total time 00:21:54]Segments with an asterisk (*) are available only with the purchase of the entire program. The Latest on the Patent Bar Exam* [00:21:54]John M. White